"「まちのお医者さん」として、「糖尿病・ 内分泌の専門医」及び 甲状腺等の「内分泌疾患の専門医」として、なんでも相談できる存在、訪れた人々に安らぎを感じてもらえる場所。とくやまクリニックは、そんなクリニックを目指しています。 そして、とくやまクリニックが運営するフィットネスジム メディカルフィットネスTOKU もご利用いただき、病気になりにくい、健康なカラダづくりをしていきましょう。 私もみなさんに寄り添い、一緒に歩んでいきたいと思います。"

During the past decade, Tokuyama Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tokuyama Clinic" are "Type 2 Diabetes" (2 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Tokuyama Clinic" in a lesser frequency.

Most popular intervention types in "Tokuyama Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Degludec" (2 trials) and "Insulin Efsitora Alfa" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tokuyama Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tokuyama Clinic". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tokuyama Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokuyama Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".